The FINANCIAL -- AstraZeneca’s Calquence (acalabrutinib), a next-generation selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in the European Union...

FDA approved AstraZeneca’s Brilinta to reduce the risk of stroke

by The FINANCIAL

November 6, 2020

The FINANCIAL -- AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability...

Astellas announced that China NMPA approved XTANDI for the treatment of prostate cancer

by The FINANCIAL

November 6, 2020

The FINANCIAL -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that the China National...

Roche to present new data across 16 blood disorders at the ASH 2020 Annual Meeting

by The FINANCIAL

November 5, 2020

The FINANCIAL -- Roche today announced that new data for its approved and investigational medicines will be presented at the...

EU approved AstraZeneca’s Forxiga for heart failure

by The FINANCIAL

November 5, 2020

The FINANCIAL -- AstraZeneca’s Forxiga (dapagliflozin) has been approved in the European Union (EU) for the treatment of symptomatic chronic heart failure...

Bayer reported sales decrease by 5.1%

by The FINANCIAL

November 3, 2020

The FINANCIAL -- Bayer reported third quarter financial results. Highlights Group sales decrease by 5.1 percent (Fx & portfolio adj.)...

EU Commission approved Roche’s Tecentriq in combination with Avastin for the treatment of people with liver cancer

by The FINANCIAL

November 2, 2020

The FINANCIAL -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Tecentriq® (atezolizumab) in...

AstraZeneca to sell commercial rights to Atacand in more than 70 countries to Cheplapharm

by The FINANCIAL

October 30, 2020

The FINANCIAL -- AstraZeneca has agreed to sell the commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (a fixed-dose combination of candesartan cilexetil...

Novo Nordisk’s operating profit increased by 6% in Danish kroner and by 7% at constant exchange rates

by The FINANCIAL

October 30, 2020

The FINANCIAL - Novo Nordisk published financial report for the period 1 January 2020 to 30 September 2020 Sales increased...

Bayer launches first Global Creative Council

by The FINANCIAL

October 29, 2020

The FINANCIAL -- Bayer launches its first Global Creative Council. This global initiative brings together senior leaders from a variety...

Lilly announced third-quarter earnings

by The FINANCIAL

October 27, 2020

The FINANCIAL -- Lilly reported Q3 financial results: - Revenue in the third quarter of 2020 increased 5 percent driven...

Gilead completed acquisition of Immunomedics

by The FINANCIAL

October 26, 2020

The FINANCIAL -- Gilead Sciences, Inc. (Nasdaq: GILD) announced the completion of the previously announced transaction to acquire Immunomedics, Inc....

Bayer acquires AskBio for $4 bln

by The FINANCIAL

October 26, 2020

The FINANCIAL -- Bayer AG today announced the acquisition of Asklepios BioPharmaceutical, Inc. (AskBio), a US-headquartered biopharmaceutical company specialized in...